Skip to main content
NIH funding notice PAR-24-106

Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)

Closed on May 30, 2024.

Posted
January 9, 2024
Close date
May 30, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $400,618 in first-year total cost, median $400,618.

Most frequent study sections

  1. Special Emphasis Panel[ZHG1 HGR-W (J1)]1

Most frequent institutions

  1. CARE PROGRESS, LLC1
Competing awards under PAR-24-106 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Leveraging Large Language Models to Enhance Regional Genomic Medicine eConsults1R43HG014149-01ISENSTEIN, HOWARDCARE PROGRESS, LLC, MD$400,618ZHG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-24-106: Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional) | ScienceDex | ConductScience